Recruiting Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma NCT06983210 Conditions Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +20 more Locations Nagoya University Hospital — Nagoya, Aichi-ken, Japan View Trial Details
